Sanford Fort Yates Dialysis is a medicare approved dialysis facility center in Fort Yates, North Dakota and it has 10 dialysis stations. It is located in Sioux county at Standing Rock Hosp, Fort Yates, ND, 58538. You can reach out to the office of Sanford Fort Yates Dialysis at (701) 854-7553. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Sanford Fort Yates Dialysis has the following ownership type - Non-Profit. It was first certified by medicare in June, 1992. The medicare id for this facility is 353505 and it accepts patients under medicare ESRD program.
| Name | Sanford Fort Yates Dialysis |
|---|---|
| Location | Standing Rock Hosp, Fort Yates, North Dakota |
| No. of Dialysis Stations | 10 |
| Medicare ID | 353505 |
| Managed By | Independent |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| Standing Rock Hosp, Fort Yates, North Dakota, 58538 | |
| (701) 854-7553 | |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
| NPI Number | 1396828547 |
| Organization Name | Sanford Fort Yates Dialysis |
| Doing Business As | Sanford Bismarck |
| Address | #10 N River Rd Fort Yates, North Dakota, 58538 |
| Phone Number | (701) 854-7553 |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 25 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 52 |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 44 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 373 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Sanford Fort Yates Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 45 |
| Hypercalcemia patient months | 379 |
| Patients with Serumphosphor | 48 |
| Patients with Serumphosphor less than 3.5 mg/dL | 6 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 13 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 22 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 34 |
| Patients with Serumphosphor greater than 7 mg/dL | 25 |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 33 |
| Patient months included in arterial venous fistula and catheter summaries | 261 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 95 |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 31 |
| Hospitalization Rate in facility | 135.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 272.4 |
| Hospitalization Rate: Lower Confidence Limit | 70.9 |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Sanford Fort Yates Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 30 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 44.5 |
| Readmission Rate: Lower Confidence Limit | 18.4 |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Sanford Fort Yates Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 2.28 (As Expected) |
| SIR: Upper Confidence Limit | 6.19 |
| SIR: Lower Confidence Limit | .58 |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Sanford Fort Yates Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 31 |
| Transfusion Rate in facility | 55.7 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 143.1 |
| Transfusion Rate: Lower Confidence Limit | 24.3 |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Sanford Fort Yates Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 168 |
| Mortality Rate in facility | 11.4 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 18 |
| Mortality Rate: Lower Confidence Limit | 6.8 |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago
Sanford Fort Yates Dialysis Location: Standing Rock Hosp, Fort Yates, North Dakota, 58538 Phone: (701) 854-7553 |
News Archive
While the overall death rate from firearm violence has remained unchanged for more than a decade, the patterns for suicide and homicide have changed dramatically, a UC Davis study on the epidemiology of gun violence from 2003 to 2012 has found.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Bayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search for promising active ingredients for innovative crop protection products.
The fight against cystic fibrosis has taken a major step forward, with pioneering research by University of Adelaide scientists showing that cells causing the debilitating genetic disorder could be successfully replaced with healthy ones.
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
› Verified 6 days ago